Eli Lilly and Co (LLY.US), a major pharmaceutical company, is set to experience a significant transaction involving one of its key shareholders. LILLY ENDOWMENT INC, a 10% stockholder, has announced plans to sell 210,000 shares of common stock with an aggregate market value of approximately $185.5 million. The sale is scheduled for 06/14/2024. The shares were originally acquired as a gift from the J.K. Lilly Sr. Trust on 02/10/1948, which had been in possession of the securities since 01/21/1937. Over the past three months, LILLY ENDOWMENT INC has sold a total of 1,105,000 shares of Eli Lilly and Co, generating gross proceeds of over $913.5 million. The upcoming sale represents a continuation of the Endowment's recent transaction activity.

Eli Lilly and Co (LLY.US), a major pharmaceutical company, is set to experience a significant transaction involving one of its key shareholders. LILLY ENDOWMENT INC, a 10% stockholder, has announced plans to sell 210,000 shares of common stock with an aggregate market value of approximately $185.5 million. The sale is scheduled for 06/14/2024. The shares were originally acquired as a gift from the J.K. Lilly Sr. Trust on 02/10/1948, which had been in possession of the securities since 01/21/1937. Over the past three months, LILLY ENDOWMENT INC has sold a total of 1,105,000 shares of Eli Lilly and Co, generating gross proceeds of over $913.5 million. The upcoming sale represents a continuation of the Endowment's recent transaction activity.